Trial Parameters
Condition Discogenic Pain
Sponsor VIVEX Biologics, Inc.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-27
Completion 2027-01-01
All Conditions
Interventions
VIA Disc NP
Brief Summary
Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.
Eligibility Criteria
Inclusion Criteria: 1. Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol 2. 18 years of age or older 3. Literate, able to speak and read English, and able to complete questionnaires independently 4. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit. Exclusion Criteria: 1. Participant did not receive VIA Disc NP injection 2. Participant is pregnant (self-reported, no special study pregnancy testing needed). 3. Any contraindications as noted in the VIA Disc NP Instructions for Use 4. Previous treatment with VIA Disc NP